Skip to content
OpenCapital
Get started

United Therapeutics UTHR Other — Total revenues

Other product segments

Tyvaso DPI
$330.3M+9.2%
Orenitram
$135.6M+12.3%
Nebulized Tyvaso
$127.2M-22.3%
Remodulin
$126.6M-8.4%
Unituxin
$53.6M-7.9%
Adcirca
$2.9M-51.7%

Similar metrics at other companies

Duolingo logo
DUOLOther — Total revenues
$682K+52.9%
Mirion Technologies logo
MIROther — Total revenues
$16.8M-4.5%
RingCentral logo
RNGOther — Total revenues
$21.03M-4.2%
Ziff Davis logo
ZDOther — Total revenues
$5.55M+47.0%
OPA
OPALOther — Total revenues
$278K-22.8%
EverCommerce Inc. logo
EVCMOther — Total revenues
$5.37M+19.4%

Other financials

Income statement

See full
Revenue$781.5M-1.6%
Gross profit$648.1M-7.7%
Operating income$325.8M-14.9%
Net income$274.9M-14.7%
EPS (diluted)$5.82-12.2%

Balance sheet

See full
Cash & equivalents$1.3B-32.6%
Total debt$12.2M—
Total equity$5.9B-13.3%
Total assets$6.7B-13.3%

Cash flow

See full
Operating cash flow$463.3M+0.5%
CapEx$100.8M+34.6%
Free cash flow$362.5M-6.2%

Valuation

See full
Market cap$23B+84.1%
P/E17.9×+7.8×
P/S7.3×+3.2×

Profitability

See full
Gross margin86.6%-2.4pp
Operating margin45.3%-1.6pp
Net margin40.6%+0.2pp
FCF margin32.1%-5.6pp

Returns & leverage

See full
Return on equity20.3%+0.3pp
Debt / equity0×—
Current ratio4.8×-0.7×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about United Therapeutics's other — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is United Therapeutics's other — total revenues?
United Therapeutics (UTHR) reported other — total revenues of $5.3M in Q1 2026.
How has United Therapeutics's other — total revenues changed year-over-year?
United Therapeutics's other — total revenues increased by 6.0% year-over-year, from $5M to $5.3M.
What does other — total revenues mean?
This metric represents the total gross income generated by the company's non-core or miscellaneous business segments that fall outside of its primary therapeutic franchises. It captures revenue streams from secondary product lines, research collaborations, or ancillary services that do not constitute the main revenue drivers of the firm. Tracking this helps investors understand the contribution of peripheral business activities to the overall top-line performance.